Akari Therapeutics Plc · NASDAQ:AKTX
Prudo-Chlebosz Raymond received 12,312 Akari Therapeutics Plc shares as an award (Form 4)
Traded Aug 18 to Oct 5, 2026 · Filed Oct 16, 2026
From Aug 18 to Oct 5, 2026, Prudo-Chlebosz Raymond (Director) received 12,312 Akari Therapeutics Plc shares as an award at US$7.90 for US$97,252, leaving 76,861 shares. Filed Oct 16, 2026 (Form 4).
- Awarded
- 12,312 shares
- Price
- US$7.90
- Value
- US$97,252
- Holding after
- 76,861 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | American Depositary Shares representing Ordinary Shares | Award | 9,072 | US$7.90 | 73,621 | Direct |
| Oct 5, 2026 | American Depositary Shares representing Ordinary Shares | Award | 3,240 | US$7.90 | 76,861 | Direct |
Source
Download original · View original at SEC